Pulmonary complications in survivors of childhood and adolescent cancer: A report from the Childhood Cancer Survivor Study

Cancer

Volumn 95, Issue 11, 2002, Pages 2431-2441

  Mertens, Ann C ^a,g   Yasui, Yutaka ^b   Liu, Yan ^b   Stovall, Marilyn ^c   Hutchinson, Ray ^d   Ginsberg, Jill ^e   Sklar, Charles ^f   Robison, Leslie L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g Division of Pediatric Epidemiology and Clinical Research   (United States)

Author keywords

Childhood cancer; Cohort; Late effects; Pulmonary; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; LOMUSTINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHITIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; COUGHING; DYSPNEA; EMPHYSEMA; FEMALE; HAY FEVER; HUMAN; INFANT; LUNG COMPLICATION; LUNG FIBROSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PLEURISY; PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SINUSITIS; STATISTICAL ANALYSIS; TONSILLITIS;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG DISEASES; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; RADIOTHERAPY; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SURVIVORS;

EID: 0036890090     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10978     Document Type: Article

References (30)

1. Ries LAG, Smith MA, Gurney JG, et al., editors. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program, 1975-1995, National Cancer Institute, SEER Program. Bethesda (MD): National Institutes of Health, National Cancer Insititute; 1999 NIH Pub. No. 99-4649.
2. Abid SH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol. 2001;13:242-248.
3. Fryer CJ, Fitzpatrick PJ, Rider WD, Poon P. Radiation pneumonitis: Experience following a large single dose of radiation. Int J Radiat Oncol Biol Phys. 1978;4:931-936.
4. Jakacki RI, Schramm CM, Donahue BR, Haas F, Allen JC. Restrictive lung disease following treatment for malignant brain tumors: A potential late effect of craniospinal irradiation. J Clin Oncol. 1995;13:1478-1485.
5. Wohl ME, Griscom NT, Traggis DG, Jaffe N. Effects of therapeutic irradiation delivered in early childhood upon subsequent lung function. Pediatrics. 1975;55:507-516.
6. Benoist MR, Lemerle J, Jean R, Rufin P, Scheinmann P, Paupe J. Effects on pulmonary function of whole lung irradiation for Wilm's tumour in children. Thorax. 1982;37:175-180.
7. van Leeuwen FE, Somers R, Taal BG, et al. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol. 1989;7:1046-1058.
8. Travis LB, Gospodarowicz M, Curtis RE, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst. 2002;94:182-192.
9. Ginsberg SJ, Comis RL. The pulmonary toxicity of antineoplastic agents. Semin Oncol. 1982;9:34-51.
10. Mertens A, Yasui Y, Neglia J, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol. 2001;19:3163-3172.
11. O'Driscoll BR, Hasleton PS, Taylor PM, Poulter LW, Gattamaneni HR, Woodcock AA. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med. 1990;323:378-382.
12. O'Driscoll BR, Kalra S, Gattamaneni HR, Woodcock AA. Late carmustine lung fibrosis. Age at treatment may influence severity and survival. Chest. 1995;107:1355-1357.
13. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Med Pediatr Oncol. 2002;38:229-239.
14. Rubin DB. Multiple Imputation for Nonresponse in Surveys, New York: John Wiley & Sons, Inc., 1987.
15. Taylor JMG, Munoz A, Bass SM, Saah AJ, Chmiel JS, Kingsley LA. Estimating the distribution of times from HIV seroconversion to AIDS using multiple imputation., Stat Med. 1990;9:505-514.
16. Therneau MT, Grambsch PM. Modeling Survival Data. Extending the Cox Model. New York: Springer, 2000.
17. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med. 1999;18:695-706.
18. Kaplan E, Sklar C, Wilmott R, Michaels S, Ghavimi F. Pulmonary function in children treated for rhabdomyosarcoma. Med Pediatr Oncol. 1996;27:79-84.
19. Miller RW, Fusner JE, Fink RJ, et al. Pulmonary function abnormalities in long-term survivors of childhood cancer. Med Pediatr Oncol. 1986;14:202-207.
20. Shaw NJ, Tweeddale PM, Eden OB. Pulmonary function in childhood leukaemia survivors. Med Pediatr Oncol. 1989;17:149-154.
21. Jenney ME, Faragher EB, Jones PH, Woodcock A. Lung function and exercise capacity in survivors of childhood leukaemia. Med Pediatr Oncol. 1995;24:222-230.
22. Nysom K, Holm K, Hertz H, Hesse B. Pulmonary function after treatment for acute lymphoblastic leukaemia in childhood. Br J Cancer. 1998;78:21-27.
23. Mefferd JM, Donaldson SS, Link MP. Pediatric Hodgkin's disease: Pulmonary, cardiac, and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys. 1989;16:679-685.
24. Marina NM, Greenwald CA, Fairclough DL, et al. Serial pulmonary function studies in children treated for newly diagnosed Hodgkin's disease with mantle radiotherapy plus cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine. Cancer. 1995;75:1706-1711.
25. Bossi G, Cerveri I, Volpini E, et al. Long-term pulmonary sequelae after treatment for childhood Hodgkin's disease. Ann Oncol. 1997;8:S19-S24.
26. Fulgoni P, Zoia MC, Corsico A, et al. Lung function in survivors of childhood acute lymphoblastic leukemia. Chest. 1999;116:1163-1167.
27. Cerveri I, Zoia MC, Fulgoni P, et al. Late pulmonary sequelae after childhood bone marrow transplantation. Thorax. 1999;54:131-135.
28. Emmons KM, Li FP, Whitton J, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2002;20:1608-1616.
29. Selikoff IJ, Hammond EC, Seidman H. Latency of asbestos disease among insulation workers in the United Sates and Canada. Cancer. 1980;46:2736.
30. Radford EP, Renard KG. Lung cancer in Swedish iron miners exposed to low doses of radon daughters. N Engl J Med. 1984;310:1485-1494.